Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-18
2006-04-18
Kim, Vickie (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S291000, C514S292000
Reexamination Certificate
active
07030129
ABSTRACT:
Methods of preventing and/or treating UV-induced immunosuppression by administration of immune response modifier compounds are disclosed herein. Suitable immune response modifier compounds include agonists of one or more TLRs.
REFERENCES:
patent: 4689338 (1987-08-01), Gerster
patent: 4698348 (1987-10-01), Gerster
patent: 4929624 (1990-05-01), Gerster et al.
patent: 4988815 (1991-01-01), Andre et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5175296 (1992-12-01), Gerster
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster
patent: 5268376 (1993-12-01), Gester
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5367076 (1994-11-01), Gerster
patent: 5376501 (1994-12-01), Mariën et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5395937 (1995-03-01), Nikolaides et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5482936 (1996-01-01), Lindstrom
patent: 5494916 (1996-02-01), Lindstrom et al.
patent: 5525612 (1996-06-01), Gerster
patent: 5605899 (1997-02-01), Gerster et al.
patent: 5693811 (1997-12-01), Lindstrom
patent: 5741908 (1998-04-01), Gerster et al.
patent: 5756747 (1998-05-01), Gerster et al.
patent: 5840732 (1998-11-01), Takatani et al.
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6028076 (2000-02-01), Hirota et al.
patent: 6028097 (2000-02-01), Okuhara et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6069149 (2000-05-01), Nanba et al.
patent: 6083505 (2000-07-01), Miller et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6194338 (2001-02-01), Andolfatto et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6200592 (2001-03-01), Tomai et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 6239116 (2001-05-01), Krieg et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6303347 (2001-10-01), Johnson et al.
patent: 6329381 (2001-12-01), Kurimoto et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6339068 (2002-01-01), Krieg et al.
patent: 6376501 (2002-04-01), Isobe et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6387938 (2002-05-01), Mizuguchi et al.
patent: 6406705 (2002-06-01), Davis et al.
patent: 6426334 (2002-07-01), Agrawal et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6455032 (2002-09-01), Kelly et al.
patent: 6476000 (2002-11-01), Agrawal
patent: 6518265 (2003-02-01), Kato et al.
patent: 6525028 (2003-02-01), Johnson et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6649172 (2003-11-01), Johnson
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6706728 (2004-03-01), Hedenstrom et al.
patent: 6743920 (2004-06-01), Lindstrom et al.
patent: 6756382 (2004-06-01), Coleman et al.
patent: 6790434 (2004-09-01), Borchert et al.
patent: 6818650 (2004-11-01), Griesgraber
patent: 2002/0016332 (2002-02-01), Slade
patent: 2002/0055517 (2002-05-01), Smith
patent: 2002/0058674 (2002-05-01), Hedenstrom et al.
patent: 2002/0110840 (2002-08-01), Tomai et al.
patent: 2003/0022302 (2003-01-01), Lewis et al.
patent: 2003/0113733 (2003-06-01), Khan et al.
patent: 2003/0129605 (2003-07-01), Yu et al.
patent: 2003/0130299 (2003-07-01), Crooks et al.
patent: 2003/0133913 (2003-07-01), Tomai et al.
patent: 2003/0134283 (2003-07-01), Peterson et al.
patent: 2003/0139364 (2003-07-01), Krieg et al.
patent: 2003/0144283 (2003-07-01), Coleman et al.
patent: 2003/0161797 (2003-08-01), Miller et al.
patent: 2003/0198609 (2003-10-01), Bunger
patent: 2003/0199461 (2003-10-01), Averett et al.
patent: 2003/0199538 (2003-10-01), Skwierczynski et al.
patent: 2004/0010007 (2004-01-01), Dellaria et al.
patent: 2004/0014779 (2004-01-01), Gorden et al.
patent: 2004/0023870 (2004-02-01), Dedera et al.
patent: 2004/0091491 (2004-05-01), Kedl et al.
patent: 2004/0132079 (2004-07-01), Gupta et al.
patent: 2004/0141950 (2004-07-01), Noelle et al.
patent: 2004/0147543 (2004-07-01), Hays et al.
patent: 2004/0162309 (2004-08-01), Gorden et al.
patent: 2004/0171086 (2004-09-01), Fink et al.
patent: 2004/0175336 (2004-09-01), Egging et al.
patent: 2004/0176367 (2004-09-01), Griesgraber et al.
patent: 2004/0180919 (2004-09-01), Miller et al.
patent: 2004/0181130 (2004-09-01), Miller et al.
patent: 2004/0181211 (2004-09-01), Graham et al.
patent: 2004/0191833 (2004-09-01), Fink et al.
patent: 2004/0192585 (2004-09-01), Owens et al.
patent: 2004/0202720 (2004-10-01), Wightman et al.
patent: 2004/0214851 (2004-10-01), Birmachu et al.
patent: 0 394 026 (1990-10-01), None
patent: 1 104 764 (2001-06-01), None
patent: 9-208584 (1997-08-01), None
patent: 9-255926 (1999-03-01), None
patent: 11-80156 (1999-03-01), None
patent: 11-222432 (1999-08-01), None
patent: 2000-247884 (2000-09-01), None
patent: WO 00/47719 (2000-08-01), None
patent: WO 00/75304 (2000-12-01), None
patent: WO 00/76505 (2000-12-01), None
patent: WO 00/76518 (2000-12-01), None
patent: WO 01/72287 (2001-10-01), None
patent: WO 01/74343 (2001-10-01), None
patent: WO 01/74343 (2001-10-01), None
patent: WO 02/36592 (2002-05-01), None
patent: WO 02/36592 (2002-05-01), None
patent: WO 02/46188 (2002-06-01), None
patent: WO 02/46188 (2002-06-01), None
patent: WO 02/46189 (2002-06-01), None
patent: WO 02/46189 (2002-06-01), None
patent: WO 02/46190 (2002-06-01), None
patent: WO 02/46190 (2002-06-01), None
patent: WO 02/46191 (2002-06-01), None
patent: WO 02/46191 (2002-06-01), None
patent: WO 02/46192 (2002-06-01), None
patent: WO 02/46192 (2002-06-01), None
patent: WO 02/46193 (2002-06-01), None
patent: WO 02/46193 (2002-06-01), None
patent: WO 02/46194 (2002-06-01), None
patent: WO 02/46194 (2002-06-01), None
patent: WO 02/46749 (2002-06-01), None
patent: WO 02/46749 (2002-06-01), None
patent: WO 02/085905 (2002-10-01), None
patent: WO 02/102377 (2002-12-01), None
patent: WO 03/020889 (2003-03-01), None
patent: WO 03/043572 (2003-05-01), None
patent: WO 03/045391 (2003-06-01), None
patent: WO 03/089602 (2003-10-01), None
patent: WO 03/097641 (2003-11-01), None
patent: WO 04/053057 (2004-06-01), None
Racchkova et al., Database Caplus (AN 2000:109451), Free radical production, immunosuppression . . . , (abstract only), Periodicum Biologorum, 1999, vol. 101(3), pp. 187-192.
Weichenthal et al., Database Caplus (AN 2000:627115), Effects of whole-body UVB irradiation on cytokine . . . , (abstract on;y), 2000, vol. 292(7), pp. 348-353.
TLR level 5- Initial Investigation , Jun. 10, 2003, NOrth American electric reliability council.
TLR infection sheet, Definition.
Twin lens reflex medium format cameras by Robert Monaghan.
Rachkova et al, Free radiacal production, immunosuppression . . . ,Periodicum biologorum, 1999, vol. 101/3, pp. 187-192.
Testerman, et al., “Cytokine Induction by the Immunomodulators Imiquimod and S-27609”,Journal of Leukocyte Biology, vol. 58, pp. 365-375, Sep. 1995.
Chollet, et al, “Development of a Topically Active Imiquimod Formulation”,Pharmaceutical Development and Technology, 4(1), pp. 34-43 (1999).
Beissert et al., “Mechanisms Involved in Ultraviolet Light-Induced Immunosuppression”,Journal of Investigative Dermatology Symposium Proceedings, 4:61-64, 1999.
Shen et al., “Modulation of IL-10, IL-12, and IFN-γ in the Epidermis of Hairless Mice by UVA (320-400 nm) and UVB (280-320 nm) Radiation”,J. Invest Dermatol, 113:1059-1064, 1999.
Nickoloff et al., “Life
Gaspari Anthony A.
Gillis Joseph A.
Miller Richard L.
3M Innovative Properties Company
Gram Christopher D.
Kim Vickie
Ringsred Ted K.
Sprague Robert W.
LandOfFree
Method of reducing and treating UVB-induced immunosuppression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing and treating UVB-induced immunosuppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing and treating UVB-induced immunosuppression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3584122